Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling

Calcified Tissue International

Volumn 58, Issue 3, 1996, Pages 166-169

  Falcini, F ^a   Trapani, S ^a   Ermini, M ^a   Brandi, M L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alendronate; Osteoporosis; Rheumatic diseases; Steroids

Indexed keywords

ALENDRONIC ACID; GLUCOCORTICOID;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE MINERAL; BONE REMODELING; CASE REPORT; CHILD; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATIC DISEASE;

ADOLESCENT; ALENDRONATE; BONE DENSITY; BONE REMODELING; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; OSTEOPOROSIS; RHEUMATIC DISEASES; SPINE;

EID: 0030001794     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900028     Document Type: Article

References (22)

1. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Int Med 112:352-364
2. Bonucci E, Dearden LC, Mosier Jr HD (1984) Effect of glucocorticoid treatment on the ultrastructure of cartilage and bone. Avd Exp Med Biol 171:269-268
3. Adachi JD, Bensen WG, Hodsman AB (1993) Corticosteroid-induced osteo-porosis. Semin Arthritis Rheum 22:375-384
4. Sambrook P, Birmingham J, Kelly P, et al. (1993) Prevention of corticosteroid osteoporosis - a comparison of calcium, calcitriol and calcitonin. N Engl J Med 328:1747-1752
5. Riggs BL, Melton LJ (1992) Drug therapy: the prevention and treatment of osteoporosis. N Engl J Med 327:620-627
6. Sorensen OH, Storm T, Thamsborg G, Soresen HA, Kollerup G, Steiniche T, Melsen F, Genant HK (1993) Bisphophonate and osteoporosis. Osteoporos Int 3:S223-S225
7. Fleish H (1993) Editorial: Prospective use of bisphosphonates in osteoporosis. J Clin End Met 76:1397-1398
8. Watts NB (1994) Treatment of osteoporosis with bisphosphonates. Rheum Dis Clin North Am 3:717-734
9. Mulder H, Struys A (1994) Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol 33:348-350
10. Bijvoet OLM, Valkema R, Lowik CWGW, Papapoulos SE (1993) Bisphosphonates in osteoporosis? Osteopor Int 3:S230-S236
11. Fleish H (1994) Bisphosphonates: pharmacology. Semin Arthritis Rheum 23:261-262
12. Fleish H (1993) New bisphosphonates in osteoporosis. Osteoporos Int 3:S15-S22
13. Valkema R, Vismans F-JFE, Papapoulos SE, et al. (1989) Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate ABD. Bone Miner 5:183-189
14. Mc Clung MR, Yates AJ (1993) Alendronate prevents or reverses bone loss at the spine and hip in recently menopausal women (abstract). J Bone Miner Res 8 (suppl 1):S141
15. Passeri M, Baroni MC, Pedrazzoni M, et al. (1991) Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate in the therapy of postmenopausal osteoporosis. Bone Miner 15:237-248
16. Santora AC, Bell NH, Chestnut CH, et al. (1993) Oral alendronate treatment of bone loss in postmenopausal osteopenic women (abstract). J Bone Miner Res 8(suppl 1):S131
17. O'Doherty, Gertz BJ, Tindal W, Sciberras DG (1992) Effect of five daily Ih infusions of alendronate in Paget's disease of bone. J Bone Miner Res 7:81-87
18. Hoekman K, Papapoulos SE, Peters ACB, Bijvoet OLM (1985) Characteristics and bisphosphonate treatment of a patient juvenile osteoporosis. J Clin End Met 61:952-956
19. Reid IR, King AR, Alexander CJ, Ibbertson HK (1988) Prevention of steroid induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (ABD). Lancet i:143-146
20. Gallacher SJ, Fenner JAK, Anderson K, Bryden FM, Banham SW, Logue FC, Cowan RA, Boyle IT (1992) Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study. Thorax 47:932-936
21. Gallacher SJ, Anderson K, Fenner JAK, Banham SW, Boyle IT (1993) A comparison of intermittent oral etidronate and intravenous pamidronate in the treatment of corticosteroidassociated osteoporosis. Calcif Tissue Int 52:S74
22. Lombardi A, Santora AC (1992) Clinical trials with bisphosphonate. Ann Ital Med Int 7(3):158S-165S